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Rational Design of a Bimodular Model System
for the Investigation of Heterocyclization
in Nonribosomal Peptide Biosynthesis
jacent aminoacyl/peptidyl-S-Ppant intermediates is cat-
alyzed by a condensation (C) domain [6, 7]. These three
core domains constitute the minimal elongation module
C-A-PCP of NRPSs [8]. The release of the final peptide
product is usually catalyzed by a thioesterase-like (Te)
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35043 Marburg domain C terminally appended to the very last module
[9, 10]. The number and organization of the iterated2Gesellschaft fu¨r Biotechnologische Forschung
mbH (GBF) modules within the enzymatic NRPSs template deter-
mine the primary structure, size, and complexity of theMascheroderweg 1
38124 Braunschweig product synthesized. The diversity of nonribosomal pep-
tides can be further enlarged by optional domains thatGermany
catalyze, e.g., epimerization [11], N-methylation [12], or
O-methylation [13, 14] and are integrated within the cor-
responding module.Summary
While integrated optional domains only lead to modifi-
cation of the corresponding substrate amino acids, vari-Cyclization (Cy) domains in NRPS catalyze the hetero-
cyclization of cysteine and serine/threonine to thiazo- ations of the peptide backbone can be obtained by the
replacement of C domains with heterocyclization (Cy)line and oxazoline rings. A model system consisting
of the first two modules of bacitracin synthetase A domains in modules processing either cysteine or ser-
ine/threonine residues [15]. The remarkable Cy domainsfused to the thioesterase (Te) domain of tyroci-
dine synthetase was constructed (BacA1-2-Te) and catalyze amide bond formation, cyclization of the side
chain nucleophile with the newly formed amides, andshown to be active in production of the heterocyclic
IleCysthiazoline. Based on this model system, the feasibil- final dehydration and are therefore responsible for the
formation of five-membered heterocyclic rings of theity of Cy domain module fusions was investigated by
replacing the BacA2 Cy-A-PCP-module with modules thiazoline and oxazoline family [16]. The sequential order
of Cy domain-catalyzed reactions has not yet been de-of MbtB and MtaD from the biosynthesis systems of
mycobactin and myxothiazol, revealing the formation termined but is thought to involve separate condensa-
tion and heterocyclization steps [17]. Once the heterocy-of novel heterocyclic dipeptides. To dissect the reac-
tion sequence of the Cy domain in peptide bond forma- cle is formed, it can be further modified by the action
of additional modifying domains [16]. Reductases liketion and heterocyclization, several residues of the
BacA1-2-Te Cy domain were analyzed by mutagene- the NADPH-dependent PchG of pyochelin synthetase
reduce the thiazoline heterocycle to the tetrahydro thia-sis. Two mutants exhibited formation of the noncyclic
dipeptide, providing clear evidence for the indepen- zolidine ring [18]. In contrast, FMN-containing oxidase
(Ox) domains [19], which are present, for instance, withindence of condensation and cyclization.
the hybrid PKS/NRPS of epothilone [20, 21], bleomycin
[22], and myxothiazol [22] biosynthesis templates, oxi-Introduction
dize the dehydro heterocycle by a two-electron transfer
to give rise to the heteroaromatic thiazole or oxazoleNumerous microorganisms utilize a nonribosomal pro-
cess for the biosynthesis of small peptides that are ring, respectively.
Cy domains and their accessory modifying domainsmainly products of secondary metabolic pathways. Syn-
thesis of these structurally diverse and pharmacologi- lead to the formation of structurally diverse heterocycles
with remarkable biochemical properties such as chela-cally interesting compounds is often mediated by multi-
modular nonribosomal peptide synthetases (NRPSs) as tion of metal ions and interaction with protein, DNA, and
RNA targets. Consequently, heterocyclic ring-containingwell as hybrid NRPS/polyketides synthase (PKS) sys-
peptides are of enormous pharmacological importance,tems [1]. Each module within these multifunctional
as documented, i.e., by the antibiotic bacitracin A (1)NRPSs represents a functional unit of catalytic domains
[23, 24] as well as the antitumor agents bleomycin [25]that is responsible for recognition, activation, and incor-
and epothilone A (2) [26] (see Figure 1). Therefore, Cyporation of one amino acid into the growing peptide
domains represent an attractive tool for the engineeringproduct. An adenylation (A) domain specifically acti-
of hybrid NRPSs and the rational design of heterocyclicvates the substrate amino acid in an ATP-dependent
ring-containing compounds with potentially novel bio-reaction to generate the corresponding aminoacyl ade-
logical activities.nylate [2, 3]. Subsequently, the aminoacyl moiety is co-
In order to establish the promising biocombinatorialvalently bound to the 4-phosphopantetheine cofactor
potential of Cy domain-containing modules, we report(Ppant) of the adjoining peptidyl carrier protein (PCP)
here on the construction and exploitation of a bimodulardomain [4, 5]. Peptide bond formation between two ad-
model system for the investigation of heterocyclization
in NRPS assembly lines. The model system constructed*Correspondence: marahiel@chemie.uni-marburg.de
consists of the first two modules of the bacitracin bio-3 Current address: DSM Biotech GmbH, Karl-Heinz-Beckurts-Straße
13, 52428 Ju¨lich, Germany. synthesis template (BacA1-2, A-PCP-Cy-A-PCP; see
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Figure 1. Five-Membered Heterocyclic Ring-
Containing Secondary Metabolites from Dif-
ferent Microorganisms
Shown are bacitracin A (1) (Bacillus licheni-
formis ATCC 10716), epothilone A (2) (Soran-
gium cellulosum So ce90), myxothiazol (3)
(Stigmatella aurantiaca DW4/3-1), and myco-
bactin A (4) (Mycobacterium tuberculosis).
Heterocyclic rings are shaded in gray.
Figure 2), which are responsible for the formation of been shown to possess a broad substrate selectivity
and to be functional when artificially fused in hybridthe N-terminal, thiazoline-containing dipeptide moiety
NRPSs [10]. Following previously described strategies,IleCysthiazoline of the peptide antibiotic bacitracin A (1).
the TycC-Te domain was genetically appended toThe Te domain of the tyrocidine synthetase C was C
BacA1-2 so that the fusion site between both enzymesterminally appended to the hybrid synthetase to ensure
was located 39 amino acids downstream of the invarianta catalytic product release.
serine residue (→ Ppant binding site) of the second PCPThe functionality of the artificial model NRPS BacA1-
[8, 28]. Thus, the resulting model system BacA1-2-Te2-Te was demonstrated by the production of the pre-
obtained had the domain order [A(Ile)-PCP-Cy-A(Cys)-dicted dipeptide IleCysthiazoline. The sequential order
PCP]BacA1-2-[Te]TycC6 (Figure 2D). For further biochemicalbetween condensation and heterocyclization was ex-
characterization, the bimodular NRPS was heterolo-amined by means of mutational studies. In addition, the
gously produced in E. coli and purified as described ingenetic exchange of module BacA2 (Cy-A-PCP) with
Experimental Procedures.other Cy domain-containing modules derived from the
A prerequisite for the formation of the expected dipep-myxothiazol (3) [14] and mycobactin (4) [27] NRPS bio-
tide IleCysthiazoline by the model system BacA1-2-Te is thesynthesis clusters was used to demonstrate the practi-
integrity and activity of its catalytic domains, especiallycability of module fusions with these special kinds of
those involved in substrate recognition and activation.heterocyclic ring-forming modules. All rationally de-
To investigate the activity of the A domains, the bimodu-signed hybrid NRPS systems were capable of producing
lar model enzyme was first subjected to amino acid-the respective oxazoline, oxazole, and thiazole-con-
dependent ATP-PPi-exchange reactions, whereby cog-taining dipeptides.
nate and noncognate amino acids were tested [29]. As
shown in Figure 3A, BacA1-2-Te revealed highest ex-Results and Discussion
change activities for the expected substrates isoleucine
(100%) and cysteine (84%) and only low side selectivityIn order to investigate heterocyclization reactions in
for the noncognate amino acids leucine (10%), valinenonribosomal peptide synthesis, we constructed an arti-
(8%), and serine (4%).ficial bimodular NRPS model system that is based on
After formation of the aminoacyl adenylate by the Athe well-characterized biosynthesis cluster of bacitracin
domain, activated amino acids are covalently tetheredA (1). This branched cyclic thiazoline-containing dodec-
to the Ppant moiety of the adjacent PCP domain. Inapeptide is produced in Bacillus licheniformis ATCC
order to probe the posttranslational modification of the
10716 on a protein template consisting of the three
PCPs with cofactor Ppant as well as the communication
NRPSs BacABC (see Figure 2A). Within the second mod-
between A and PCP domains, covalent loading assays
ule of BacA, the optional Cy domain, catalyzing forma-
using radiolabeled amino acids were conducted [29].
tion of the N-terminal thiazoline ring, replaces the usual As expected, both substrate amino acids, Ile and Cys,
C domain. could be efficiently loaded onto the Ppant-carrier arm
of the PCP domains in the presence of ATP (data not
The Bimodular Model System BacA1-2-Te shown).
The bimodular model system that we constructed con- After the activity of the individual domains had been
sists of the first two modules of the bacitracin biosyn- confirmed, we next investigated the capability of the
thetic system (BacA1-2, A-PCP/Cy-A-PCP; Figure 2A). bimodular model NRPS to catalyze the formation of the
The two modules specifically activate isoleucine and expected dipeptide product. To this end, BacA1-2-Te
cysteine, respectively, and are capable of forming the was incubated with ATP, isoleucine, and cysteine. At
dipeptide IleCysthiazoline. In order to obtain multiple cata- certain time points, samples were taken and immedi-
lytic turnovers, we fused the Te domain of tyrocidine ately quenched and analyzed by HPLC/MS. As shown
synthetase C (TycC) to the C terminus of the bimodular in Figure 3B, incubation of BacA1-2-Te with its sub-
system. Te domains of different NRPSs catalyze the strates led to the time-dependent formation of the ex-
pected thiazoline-containing product isoleucinyl-thia-release of the respective peptide products. They have
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Figure 2. Biosynthesis Systems from which the Used Domains Originate and the Constructed Hybrid Peptide Synthetases
(A) The three enzymes involved in biosynthesis of bacitracin A are encoded by the genes bacABC. The Cy domain is located between the
first and second module.
(B) Mycobactin synthesis is catalyzed by a PKS/NRPS hybrid system. The NRPS module of MbtB contains a threonine-processing Cy domain.
(C) Myxothiazol is also produced by a PKS/NRPS biosynthesis system. Two Cy domains are located in MtaC and MtaD. Domains and modules
utilized in this study are shaded in gray.
(D) Hybrid bimodular NRPSs investigated in this study and their expected catalytic products. The expected product of this model synthetase
BacA1-2-Te is the thiazoline-containing dipeptide IleCysthiazoline (5). The hybrid synthetases BacA1-MbtB-Te and BacA1-MtaD-Te were assumed
to produce the oxazoline-containing products IleThroxazoline (6) and IleSeroxazoline (7) (C) as well as the thiazole-product IleCysthiazole (8). Adenylation
domains are identified by the three-letter code of the substrate. C, condensation domain; Cy, heterocyclization domain; E, epimerization
domain; PCP, peptidyl carrier protein; Te, thioesterase domain; MOX, monooxygenase domain; O-MT, O-methyl transferase; Ox, oxidation
domain; ACP, acyl carrier protein; AT acyl transferase; DH, -hydroxy-acyl-ACP dehydratase; KR, -ketoacyl-ACP reductase; KS -ketoacyl-
ACP synthase; S, spacer region.
zolinyl-cysteine (IleCysthiazoline) (5). The identity of this substrate amino acid or ATP. The requirement of the Te
domain for the product release is supported by analysisproduct was confirmed by coupled ESI-MS analysis (at
14.3 min: [MH]  217 m/z, calculated mass 217 m/z; of the BacA1-2-enzyme, which has no Te fused. This
construct shows absolutely no product formation (data[MNa]  239 m/z). In addition, a byproduct was de-
tected at 17.2 min (retention time), which could be as- not shown).
The presented data clearly show that fusion of the Cysigned to the thiazoline-containing tripeptide isoleu-
cinyl-thiazolinyl-cysteinyl-cysteine (9) (IleCysthiazolineCys, domain-containing bimodule BacA1-2 with the TycC-Te
domain led to the successful construction of a bimodularcalculated mass [MH] 320 m/z; [MNa] 342 m/z).
This byproduct is presumably formed by a noncatalyzed model NRPS, which can be exploited for the in vitro
investigation of heterocyclization reactions in nonribo-transthioesterification of the enzyme-bound IleCysthiazoline-
S-Ppant intermediate onto the thiol moiety of free cys- somal peptide biosynthesis. Both the activity of BacA1-
2-Te and its robust turnover of the expected IleCysthiazolineteine molecules. Similar byproducts have already been
reported for in vitro experiments with the yersiniabactin product illustrate the practicability and potential of ratio-
nally designed hybrid NRPSs with Cy domain-containingNRPS [30]. In a control reaction, we verified that no
product was formed in the absence of one or the other modules. Furthermore, the result obtained for BacA1-
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Figure 3. Biochemical Investigation of the Model System BacA1-2-Te
(A) The ATP-PPi-exchange reaction of the model system BacA1-2-Te showed specific activation of isoleucine and cysteine.
(B) HPLC/MS analysis of product formation catalyzed by BacA1-2-Te showed time-dependent formation of two different products.
(C and D) The peaks at 14.3 min and 17.2 min could be assigned to the expected product IleCysthiazoline (5) ([MH]  217 m/z; [MNa] 
239 m/z) and the noncatalytically formed product IleCysthiazolineCys (9) ([MH]  320 m/z; [MNa]  342 m/z; [MK]  358 m/z), respectively.
2-Te demonstrates once again the versatility of NRPS (Ox) domain embedded between the core motifs A8 and
A9 of the Cys-activating A domain catalyzes a two-elec-Te domains, since the TycC Te domain used in this
work apparently also catalyzes the release of unusual tron transfer. Consequently, the corresponding module
effects the incorporation of a heterocyclic thiazole ringproducts such as the thiazoline-containing dipeptide
IleCysthiazoline. (Figure 1).
For practical realization of the module swaps, the fol-
lowing two issues had to be kept in mind. First, it hasHybrid Bimodular Constructs
The engineered bimodular model system BacA1-2-Te been shown that C domains are selective for their re-
spective acceptor amino acid, distinguishing both theprovides the basis for an exploitation of the biocombina-
torial potential of Cy domain-containing modules. Up to chirality and the size of the side chain of the incoming
monomeric nucleophile [32]. Taking into considerationnow, analogous attempts for the construction of hybrid
NRPSs were restricted to the fusion of modules con- the significant structural and functional homology be-
tween C and Cy domains, an analogous acceptor sitesisting only of the basic core domains C, A, and PCP
[8, 28, 31]. In order to demonstrate the practicality of selectivity of the Cy domains could not be excluded.
Consequently, we decided to maintain the natural Cy-Acomparable approaches for Cy domain-containing mod-
ules, we next set out to genetically substitute the original junction and to use whole Cy-A-PCP modules. Second,
based on strategies previously described for the con-BacA2 Cy-A-PCP module of the model system with anal-
ogous modules derived from the mycobactin and myxo- struction of hybrid NRPSs, the optimal fusion site be-
tween PCP and C (or Cy) domains is located within short,thiazol NRPS cluster. The second module (MbtB) of the
mycobactin NRPS of Mycobacterium tuberculosis has nonconserved linker regions between the dedicated do-
mains. Following this rule, the BacA1 module and thethe domain arrangement Cy-A(Thr/Ser)-PCP (Figure 2B)
and catalyzes the incorporation of the oxazoline hetero- respective Cy domain-containing module were fused 38
amino acids downstream of the strictly conserved serinecyclic ring (Figure 1) [27]. The fourth module (MtaD)
of the myxothiazol biosynthetic cluster of Stigmatella residue (→ Ppant binding site) of the PCPBacA1 domain
and 21 or 23 amino acids upstream of the core motifaurantiaca DW4/3-1, in contrast, has the domain organi-
zation Cy-A(Cys)Ox-PCP (Figure 2C). Here, the oxidation Cy1 of the Cy domains of MtaD and MbtB, respectively
Heterocyclization in Hybrid NRPSs
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Figure 4. Biochemical Investigation of the Hybrid Synthetases BacA1-MbtB-Te and BacA1-MtaD-Te
(A) ATP-PPi-exchange reaction showed expected activation of isoleucine, threonine, and serine by BacA1-MbtB-Te.
(B) Incubation of BacA1-MbtB-Te with the substrates isoleucine and threonine led to the formation of IleThroxazoline (6) (9.7 min, [MH]  215
m/z).
(C) Formation of IleSeroxazoline (7) (12.3 min, [MH]  201 m/z) could be detected after incubation with isoleucine and serine.
(D) BacA1-Mta-Te recognized isoleucine, but only low activity could be observed for the second cognate amino acid cysteine. Instead,
unexpected activation of threonine and serine was found.
(E) The hybrid synthetase BacA1-MtaD-Te was able to synthesize IleThroxazole (10) (9.6 min, [MH]  213 m/z) when incubated with isoleucine
and threonine.
(F) IleCysthiazole(8) (12.1 min, [MH]  215 m/z) was found when the enzyme was provided with isoleucine and cysteine.
[15]. Likewise, and as already described for the con- were also shown to be covalently incorporated into the
hybrid enzyme, using the radioactive thioester formationstruction of the model system BacA1-2-Te, the Te do-
main of TycC was fused 38 amino acids downstream of assay (data not shown).
A striking feature of the initial tests of the hybrid NRPSthe conserved serine residue of the PCP domain of MtaD
and MbtB. BacA1-MbtB-Te was the high tolerance for the noncog-
nate serine. This side selectivity, however, apparentlySuccessive engineering led to the bimodular hybrid
systems BacA1-MbtB-Te (domain arrangement [A(Ile)- represents a peculiarity of threonine-activating A do-
mains (as present, i.e., in module MbtB) and has alreadyPCP]BacA1-[Cy-A(Thr)-PCP]MbtB-[Te]TycC6), and BacA1-MtaD-
Te ([A(Ile)-PCP]BacA1-[Cy-A(Cys)Ox-PCP]MtaD-[Te]TycC6) (Fig- been described for other systems, e.g., vibriobactin from
Vibrio cholerae [33]. Likewise, concomitant activation ofure 2D). After heterologous production and purification,
both hybrid enzymes were investigated for their catalytic serine and threonine by MbtB in the mycobactin system
leads to the formation of oxazoline and -methyl oxazo-activities and product formation according to the proce-
dures described for the model system BacA1-2-Te. line-containing derivatives, respectively. Correspond-
ingly, the observed serine selectivity of hybrid synthe-The hybrid construct BacA1-MbtB-Te, comprising the
initiation module of BacA1, the Cy-A-PCP module of tases BacA1-MbtB-Te is apparently not evoked by the
artificial fusions, but rather an inherent feature of theMbtB, and the TycC-Te domain, was first tested using
amino acid-dependent ATP-PPi-exchange reactions. threonine-activating A domain of MbtB.
Product formation activity of the hybrid synthetasesThis assay revealed the expected activation of the sub-
strates isoleucine (100%) and threonine (95%) as well BacA1-MbtB-Te was investigated, similarly to BacA1-
2-Te, by coupled HPLC/MS analysis. As expected fromas side selectivity for the noncognate amino acids serine
(51%), valine (25%), leucine (13%), and cysteine (3%) the results of the ATP-PPi-exchange reactions, the hy-
brid NRPS was able to synthesize both dipeptides, iso-(Figure 4A). Both amino acids isoleucine and threonine
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leucinyl-oxazolinyl-threonine (IleThroxazoline) (6) (at 9.7 min, predictions made by the selectivity-conferring code of
NRPS A domains and (2) the primary structure of the[MH]  215 m/z, calculated mass 215 m/z) and iso-
leucinyl-oxazolinyl-serine (IleSeroxazoline) (7) (12.3 min, peptide antibiotic myxothiazol. Surprisingly, amino acid-
dependent ATP-PPi-exchange reactions revealed high-[MH]  201 m/z, calculated mass 201 m/z), once
provided with the corresponding substrate amino acids est exchange activity with noncognate amino acids thre-
onine and serine. From both substrates, only threonine(Figures 4B and 4C). However, productivity of the hybrid
synthetases BacA1-MbtB-Te was significantly impaired but not serine was incorporated into the dipeptide prod-
uct synthesized, indicating that the MtaD-Cy domainin both cases. Compared to the model system, we ob-
served an approximately 80-fold decrease of product apparently rejects serine. Even more striking was the
observation that the hybrid enzyme BacA1-MtaD-Teformation.
The second hybrid synthetase BacA1-MtaD-Te, com- did form the -methyl oxazole-containing dipeptide
IleThroxazole (10), although the native myxothiazol biosyn-prising the initiation module of BacA1, the Cy-A(Ox)-
PCP module of MtaD, and the TycC-Te domain, was thesis system only synthesizes the thiazole-containing
product. Feeding experiments with the producer strainalso first analyzed in amino acid-dependent ATP-PPi-
exchange reactions. Considering both the primary struc- Stigmatella aurantiaca DW 4/3-1 verified that exclusively
cysteine is incorporated into the product [34], and noture of the natural product myxothiazol [Figure 1 (3)] [34]
and the predictions made by the selectivity-conferring oxazole-containing variants are formed in vivo. Appar-
ently, some editing barrier provided by the wild-typecode (data not shown) [35], module MtaD was believed
to recognize and activate Cys. Surprisingly, however, myxothiazol synthetase complex, which is missing in
the hybrid enzyme BacA1-MtaD-Te, prevents the pro-the assay revealed highest exchange activities for iso-
leucine (100%), threonine (91%), and serine (40%), cessing of threonine and formation of an oxazole-con-
taining derivative. Recent studies support the idea ofwhereas the proposed substrate amino acid cysteine
was activated only inefficiently by BacA1-MtaD-Te (8%). an effective editing function, since the deletion of the
MtaD-Ox domain in the native myxothiazol system didFurthermore, the hybrid enzyme revealed tolerance for
the activation of the noncognate amino acids valine not lead to formation of a thiazoline product but to a
nonproducing S. aurantiaca strain [36].(31%), phenylalanine (12%), and leucine (7%) (Figure
4D). The results of the ATP-PPi-exchange reaction could The Ox domain of MtaD, which is integrated into the
A domain, represents a very interesting member of thebe confirmed by the thioester formation assay, which
revealed the covalent incorporation of isoleucine and group of optional NRPS domains. The activity of the Ox
domain in the BacA1-MtaD-Te-hybrid enzyme confirmsthreonine into the hybrid enzyme. Notwithstanding the
observed low activation by BacA1-MtaD-Te, we found previous studies that have shown that flavo-enzymes
can be heterologously expressed in E. coli and purifiedthat small amounts of cysteine could also be covalently
loaded onto the enzyme (data not shown). in their FMN-containing form [22]. Recently, the Ox do-
main of epothilone synthetase B was purified as an ac-A special feature of the hybrid synthetase BacA1-
MtaD-Te is the presence of an Ox domain inserted into tive, stand-alone FMN-containing holo-enzyme [19]. In
the same work, it was shown that the FMNH2-Ox domainthe A domain and catalyzing oxidation of the heterocy-
clic rings to give rise to the corresponding thiazole and can be regenerated by molecular oxygen. Presumably,
this oxygen-dependent regeneration guarantees the ac-oxazole derivatives. Thus, given the demonstrated acti-
vation of isoleucine (by module BacA1) as well as threo- tivity of the MtaD-Ox domain in the synthetase BacA1-
MtaD-Te.nine and serine (by module MtaD), the hybrid NRPS
should be capable of synthesizing the -methyl oxazole As demonstrated by the production of -methyl oxa-
zole and thiazole-containing dipeptides IleThroxazole andand oxazole-containing dipeptides isoleucinyl-oxazolyl-
threonine (IleThroxazole) (10) and isoleucinyl-oxazolyl-ser- IleCysthiazole, the Ox domain of MtaD exhibits, like TycC-
Te domain, broad substrate selectivity, making it a ver-ine (IleSeroxazole). Surprisingly, however, only production
of the -methyl oxazole-containing dipeptide IleThroxazole satile tool for rational design of hybrid NRPSs. This bio-
combinatorial potential of optional Ox domains may be(9.6 min, [MH]  213 m/z; calculated mass 213 m/z)
could be demonstrated (Figure 4E), while no formation exploited in the future for the production of unprece-
dented thiazole- and oxazole-containing hybrid peptideof the IleSeroxazole product was observed. In an additional
experiment, product formation by BacA1-MtaD-Te was antibiotics.
investigated in the presence of substrates ATP, isoleu-
cine, and cysteine, although the A domain of module
Cy Domain MutantsMtaD exhibited only low side selectivity for cysteine
Cy domains are optional domains of NRPS assemblyin the ATP-PPi-exchange reaction. HPLC/MS analy-
lines that replace conventional C domains in modulessis revealed formation of isoleucinyl-thiazolyl-cystein
that incorporate cysteine or serine/threonine residues(IleCysthiazole) (8) (12.1 min, [MH]  215 m/z, calculated
by heterocyclization rather than simple amide bond or-mass 215 m/z) (Figure 4F), indicating that even low ade-
mation. The formation of the thiazoline and oxazolinenylation activity may be sufficient to bring about biosyn-
rings requires three reaction steps: the condensationthesis of the thiazole-containing dipeptide product.
of the substrates, the formation of the five-memberedBiochemical in vitro analysis of hybrid synthetase
heterocyclic ring, and the final dehydration. As shownBacA1-MtaD-Te revealed several intriguing results that
in Figure 5B, two different routes are feasible to achieveall can be traced back to the selectivity of individual
this goal [16]. The peptide bond could be formed first,domains of module MtaD (Cy-A(Ox)-PCP). The A domain
of MtaD was believed to activate cysteine given (1) the followed by the cyclization of the side chains and the
Heterocyclization in Hybrid NRPSs
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Figure 5. Partial Sequence Alignment of Cy Domains and Possible Reaction Mechanism
(A) Included are VibF Cy1 and Cy2 from the Vibrio cholerae vibriobactin synthetase, the Cy domains of BacA2 (bacitracin synthetase,
B. licheniformis), HMWP1 (yersiniabactin synthetase, Y. pestis), MbtB (mycobactin synthetase, M. tuberculosis), MtaD (myxothiazol synthetase,
S. aurantiaca), and the second Cy domain of BlmIV (Bleomycin synthetase S. verticillus). Residues conserved in at least four domains are
boxed. Residues conserved in at least six domains are marked black. Residues that were mutated in the Cy domain of the model system
BacA1-2-Te are indicated with arrows. The amino acids of the putative solvent channel are bulleted.
(B) Model for the reaction sequence of heterocyclization exemplified by the first two modules of bacitracin synthetase A. In the first step, the
enzyme-bound amino acids are combined by a nucleophilic attack of either the cysteine amino group (a) or the heteroatom of the side chain
(b) onto the carbonyl C of isoleucine. Next, a proton is abstracted by means of base catalysis, thereby enabling the attack of either the
cysteine side chain or the amino group onto the amide bond carbonyl. This leads to the formation of a hydroxylated thiazolidine intermediate,
which is subsequently dehydrated to give the final thiazoline-containing product.
final dehydration. Alternatively, a nucleophilic attack of shown to catalyze only peptide bond formation between
2,3-dihydroxybenzoate and threonine but was not ablethe side-chain hydroxyl or thiol group could lead first
to the formation of an oxoester or thioester, which is to perform cyclization of the side-chain nucleophile to
form the corresponding heterocyclic ring [17, 33]. Sec-then further processed to yield the final five-membered
heterocyclic ring product. In order to determine the ondly, previous studies revealed that the highly con-
served motif DxxxxD located between the core motifschronological order of condensation and cyclization in
the course of heterocyclization, we used mutational Cy2 and Cy3 is the Cy domain equivalent for the catalytic
core of C domains (HHxxxDG) [7, 15, 17], indicatinganalysis of the Cy domain of our model system BacA1-
2-Te. that this N-terminal portion of the Cy domains may be
involved in the peptide bond-forming reaction only (Fig-Cy domains share striking structural and functional
homology with C domains, which catalyze basic peptide ure 5). Thus, in order to identify residues involved in
cyclization but not peptide bond formation, we focusedbond formation only. Consequently, our goal was to
identify those residues that distinguish Cy domains from on the C-terminal portion of the Cy domains and carried
out sequence comparisons between VibF-Cy2 and dif-C domains and are probably essential for cyclization of
the side chain (see Figure 5) but are not involved in ferent Cy domains.
Figure 5A shows the sequence alignment of a stretchpeptide bond formation. In order to determine possible
candidates for the mutational analysis, we considered of approximately 120 aa between the core motifs Cy4
and Cy6 [15] (positions 872–987; numbering in accor-two important observations concerning NRPS Cy do-
mains. First, the NRPS VibF involved in the biosynthesis dance with the amino acid sequence of BacA). Within
this region, we found nine invariant residues conservedof vibriobactin in Vibrio cholerae was shown to possess
the unusual domain arrangement Cy-Cy-A-C-PCP-C. In- between VibF-Cy2 and other Cy domains as well as nine
residues that are strictly conserved among Cy domainsterestingly, although the second Cy domain shares high-
est homology with other known Cy domains, it was but not present in VibF-Cy2. Among these latter resi-
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dues, positions 904, 932, and 982 revealed only conser-
vative substitutions between hydrophobic amino acids,
and thus only the remaining six residues (T875, N900,
R906, D919, F920, and S984) were selected and mutated
to alanine. Mutation of position F920 failed for unknown
reasons, but the remaining five mutants, BacA1-2-Te
T875A, BacA1-2-Te N900A, BacA1-2-Te D919A, BacA1-
2-Te R906A, and BacA1-2-Te S984A, were constructed
successfully.
All five mutants were heterologously expressed in
E. coli, purified to near homogeneity, and biochemically
characterized using amino acid-dependent ATP-PPi-
exchange reactions as well as the covalent loading of
radioactively labeled amino acids. These studies re-
vealed that the mutant enzymes were not impaired in
the activity and intramodular communication of the A
and PCP domains compared with model system BacA1-
2-Te. In order to investigate the activity of the mutated
Cy domains, product formation assays were carried out
as described above. On the supposition that the con-
structed Cy domain mutants may be affected in cycliza-
tion but not condensation activity, formation of the linear
Figure 6. HPLC/MS Analysis of Product Formation Catalyzed by thedipeptide isoleucinyl-cysteine (IleCys) (11) could be ex-
Cy Domain Mutants
pected.
(A) The linear dipeptide IleCys (11) (12.8 min, [MH]  235 m/z)As demonstrated by HPLC/MS analysis of the reaction
was expected in cases where cyclization but not condensation was
mixtures, the five mutant NRPSs can be categorized affected.
into three groups as follows. (B) Formation of a disulphide bond between two IleCys monomers
led to the appearance of the dimerization product (IleCys)2 (21.2Mutants BacA1-2-Te T875A and BacA1-2-Te R906A
min, [MH]  467 m/z) (12).form the first group. Both encoded proteins failed to
produce thiazoline-containing IleCysthiazoline (5) or linear
IleCys (11), indicating that the mutations lead to an inac-
cant structural and functional homology. Therefore, thetive Cy domain incapable of catalyzing condensation
crystal structure of the free-standing C domain VibHand/or cyclization. In this connection, it has to be
was supposed to be representative of the whole super-stressed again that all constructs tested were not af-
family of condensation, epimerization, and cyclizationfected in the activation and covalent loading of their
domains [6]. Consequently, the existing structure ofsubstrate amino acids.
VibH can be exploited to discuss the possible function ofMutant BacA1-2-Te D919A revealed the same activity
the conserved Cy domain residues under investigation.as the basic model BacA1-2-Te, indicating that this resi-
Sequence comparison between C and Cy domainsdue, although conserved between Cy domains, is not
revealed 13 conserved amino acid residues, of whichinvolved in the catalytic mechanism of the Cy domain.
the residue R906 is the only one that was investigatedHPLC/MS analysis revealed the formation of both the
in this study. The 906-corresponding residue in the Cthiazoline-containing dipeptide IleCysthiazoline (5) (at 14.1
domain was shown to be uninvolved in catalysis [7]. Inmin, [MH]  217 m/z, calculated mass 217 m/z) and
contrast, the mutation R906A in BacA1-2-Te R906A ledthe byproduct IleCysthiazolineCys (9) (at 17.1 min, [MH]
to an inactive enzyme, indicating an important role in320 m/z, calculated [MH]  320 m/z). In addition, no
Cy domain function. Presumably, the mutation of R906Adifferences in productivity could be observed compared
led to structural alterations that affect the catalytic activ-to the model system.
ity. From the crystal structure of VibH, it was concludedFinally, mutants BacA1-2-Te N900A and BacA1-2-Te
that R906 forms hydrogen bonds with other residuesS984A were affected in cyclization but not condensation
located within the solvent channel. Thus, mutation ofactivity. In both cases, HPLC/MS analysis confirmed the
R906 prevents formation of these hydrogen bonds thatproduction of expected linear dipeptide IleCys (11) at
may cause structural changes, which will ultimately lead12.8 min with the [MH] ion peak of 235 m/z (calculated
to an inactive Cy domain. In VibF-Cy2, which was alsomass [MH]  235 m/z). In addition, formation of di-
mutated and proved the opposite, other residues maymerized product (IleCys)2 (12) could be observed (at 21.2
take over that function.min, [MH]  467 m/z, calculated mass [MH] 467
Like R906, residues N900 and S984 are also proposedm/z) (Figure 6). Here, dimerization is caused by the for-
to be involved in the formation of the solvent channel.mation of a disulfide bond between the free thiol resi-
Both mutants, BacA1-2-Te N900A and BacA1-2-Tedues of the incorporated cysteine moieties. Conse-
S984A, were affected in cyclization but not condensa-quently, since only the noncyclized product contains
tion activity. This observation confirmed studies on VibFa free thiol group, detection of (IleCys)2 dimer is only
that revealed a clear separation of condensation andconsistent with preceding formation of the linear di-
cyclization catalyzed by the tandem domains Cy2 andpeptide.
As mentioned above, C and Cy domains share signifi- Cy1, respectively [17, 33]. Secondary structure predic-
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Table 1. Primers Used in This Study
Primer Name Nucleotide Sequence
5-bacA1-A 5-TATACCATGGTTGCTAAACATTCATTAG-3
3-bacA2-T 5-TTAAGATCTGTTTTTCAAATAGTGGTCC-3
5-tycTe 5-ATAAGATCTCATAAGCGCTTTGAGAGCAG-3
3-tycTe 5-TATGGATCCTTTCAGGATGAACAGTTCTTG-3
3-bacA1-T 5-TATGGATCCTTCGATAAAAGCGCTCAATTC-3
5-mbtB-Cy 5-ATAAGATCTACCGGCGTCGCGCCCAC-3
3-mbtB-T 5-AATAGATCTGGTGAGCAACTGGGCCAACG-3
5-mtaD-Cy 5-ATTAGATCTCGCTCCGCGAATCTTCAG-3
3-mtaD-T 5-ATAAGATCTGTGGATGAACTCCGCCAG-3
CyT875A 5-CGGCATCATCATCTCGCACCGACTTCCGTCCTTTG-3
CyT875Arev 5-CAAAGGACGGAAGTCGGTGCGAGATGATGATGCCG-3
CyN900A 5-CGGCAAAATCATTTTGCTATCGCGTTAACCGTATTTAACAGAATCCCG-3
CyN900Arev 5-CGGGATTCTGTTAAATACGGTTAACGCGATAGCAAAATGATTTTGCCG-3
CyR906A 5-GCTATCAATTTAACCGTATTTAACGCGATCCCGTTTCATCCGGATGTCAAG-3
CyR906Arev 5-CTTGACATCCGGATGAAACGGGATCGCGTTAAATACGGTTAAATTGATAGC-3
CyD919A 5-GGATGTCAAGAACATGATCGGAGCCTTTACCTCTTTAATGCTGCTGG-3
CyD919Arev 5-CCAGCAGCATTAAAGAGGTAAAGGCTCCGATCATGTTCTTGACATCC-3
CyS984A 5-GCCGATCGTATTCACAGCTGTGCTGATTGAAAATCCC-3
CyS984Arev 5-GGGATTTTCACTCAGCACAGCTGTGAATACGATCGGC-3
Restriction sites are underlined, and mutated codons are in bold.
tions and comparison with the structure of VibH [6] indi- be exploited for the production of unprecedented het-
erocyclic ring-containing peptide antibiotics.cated that N900 is localized in the  strand 9, whereas
S984 is part of  strand 11. Both residues are placed in
Experimental Proceduresthe region of the solvent channel, which was described
to pinpoint the C domain’s active site. Apparently, cycli-
Bacterial Strains and Culture Mediazation in Cy domains is catalyzed in the same solvent
Escherichia coli strains Top10F (Invitrogen) and XL1-blue (Stra-
channel, but by different residues, as the condensation tagene) were used for the construction and maintenance of the
reaction. expression plasmids, whereas gene expressions were carried out
in derivatives of E. coli BL21(DE3) (Stratagene). All cells were grown
in LB medium [37] supplemented, if appropriate, with 25 g/mlSignificance
kanamycin and 100 g/ml ampicillin (final concentrations).
The rational design of NRPS templates is an important
Construction of Expression Plasmidsapproach for the synthesis of novel peptide antibiotics.
All gene fragments required for the construction of the expression
The structural diversity of these peptides is especially plasmids were amplified by using the Expand long-range kit (Roche).
enhanced by structural particularities, which are nor- Modified oligonucleotides for mutagenesis and introduction of re-
striction sites for subsequent cloning were purchased from MWGmally affected by optional domains within the multi-
Biotech and Qiagen Operon. Primers used in this study are listedmodular enzyme templates. One of the most remark-
in Table 1.able optional domains is the Cy domain, responsible
The plasmid p[A-PCP-Cy-A-PCP]bacA1-2-[Te]tycC6 for the overpro-for the incorporation of five-membered rings of the
duction of the model system BacA1-2-Te is a derivative of pQE60
thiazoline and oxazoline type by heterocyclization of vector (Qiagen). The 4956 bp gene fragment comprising bacA1-2
cysteine and serine/threonine side chains. We report was amplified from chromosomal DNA of Bacillus licheniformis
ATCC 10716 using the primers 5-bacA1-A and 3-bacA2-T (seehere the construction and exploitation of a bimodular
Table 1). After digestion with the endonucleases NcoI and BglII, themodel system for the investigation of heterocycliza-
fragment was ligated into pQE60, previously cut in the same mannertion in NRPS assembly lines. The functionality of the
to give p[A-PCP-Cy-A-PCP]bacA1-2. Subsequently, the 756 bp geneartificial model NRPS engineered was demonstrated
fragment encoding the Te domain of tyrocidine synthetase C (TycC)
by the production of the expected heterocyclic ring- was amplified from chromosomal DNA of Bacillus brevis ATCC 8185
containing dipeptide. Heterocyclization requires suc- by using the oligonucleotides 5-tycTe and 3-tycTe digested with
BglII and BamHI and ligated into the BglII-linearized plasmid p[A-cessive peptide bond formation, cyclization of the side
PCP-Cy-A-PCP]bacA1-2 to give p[A-PCP-Cy-A-PCP]bacA1-2-[Te]tycC6.chain, and dehydration. We examined the sequential
Plasmids for the overproduction of the hybrid bimodular NRPSsorder of heterocyclization by means of mutational
are based on the pQE60-derivative p[A-PCP]bacA1. This plasmid wasanalysis of the Cy domain and confirmed the indepen-
constructed by amplification of the bacA1gene from chromosomal
dence of both condensation and cyclization reaction. DNA of Bacillus licheniformis ATCC 10716 using the primers 5-
In addition, the genetic exchange of various Cy do- bacA1-A and 3-bacA1-T. After digestion with the endonucleases
NcoI and BamHI, the 1829 bp DNA fragment was ligated into pQE60,main-containing modules derived from different bio-
which was cut in the same manner. Subsequently, the 3165 bp genesynthetic systems demonstrated the practicability of
fragment encoding [Cy-A-PCP]mbtB was amplified from the plasmidmodule fusions with this special kind of heterocyclic
pET28-mbtB using the oligonucleotides 5-mbtB-Cy and 3-mbtB-ring-forming module. Likewise, the engineered hybrid
T. At the same time, the 4002 bp gene fragment comprising mtaD
NRPSs proved the biocombinatorial potential of op- was amplified from the cosmid E25 [14] utilizing the oligonucleotides
tional Ox domains. Thus, our study paves the way for 5-mtaD-Cy and 3-mtaD-T. Both fragments were digested with BglII
and ligated into the BglII/BamHI site of the plasmid p[A-PCP]bacA1,the rational engineering of hybrid NRPSs, which may
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